Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT2080221500
JPRN-jRCT2080221500
Unknown
Phase 2

ong-term Prevention of Recurrent Gastric or Duodenal Ulcers caused by Low-dose Aspirin with Rabeprazole (E3810) Treatment. -A Multicenter, Randomized, Parallel-group, Open-label Trial-(Planetarium study)

Eisai Co., Ltd.0 sites300 target enrollmentStarted: June 29, 2011Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Enrollment
300
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • •Confirmed to have no recurrence of gastric or duodenal ulcer by endoscopy at the end of 24 weeks of treatment in Trial 308\.
  • •Need to continue receiving low\-dose aspirin (81 mg/day or 100 mg/day) during this trial.

Exclusion Criteria

  • •Confirmed to have a recurrence of gastric or duodenal ulcer at the end of 24 weeks of treatment in Trial 308 (at the start of this trial) and thus are withdrawn from the trial.

Investigators

Similar Trials

Unknown
Phase 2
Efficacy of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriGastric or duodenal ulcers caused by low-dose aspirin
JPRN-jRCT2080221499Eisai Co., Ltd.450
Completed
Phase 2
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)Gastric or Duodenal Ulcers Caused by Low-dose Aspirin
NCT01397448Eisai Co., Ltd.472
Active, not recruiting
Phase 1
Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidine
EUCTR2005-004849-33-GBHS Greater Glasgow700
Recruiting
Not Applicable
Prevention of gastrointestinal complications by infusion pump in patients receiving enteral nutritioInpatients receiving enteral nutrition via nasogastric tube, gastric fistula, or intestinal fistula
JPRN-UMIN000005609Division of Clinical pharmacokinetics, Faculty of Pharmacy, Keio University200
Recruiting
Phase 4
It is the study to compare non surgical treatment modality for gastroduodenal obstructio
CTRI/2020/07/026501SMS Hospital and medical college